|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | A faster strongly polynomial time algorithm for submodular function minimization显示文摘 | Odin J B | 2009 | Mathematical Programming2009，118，2： | 1 |
| 2 | Cortieosteroid-bind- ing globulin : A possible early predictor of infection in acute neero- tizing panereatitis 显示文摘 | Chridtophe AM Odin B Michael V | 2007 | Seand J Gastroenterol2007，42，11： | 1 |
| 3 | Carotid artery intima-media thickness in patients with Type 2 diabetes mellitus and impaired glucose tolerance : a systematic review 显示文摘 | Brohall G Odin A Fagerberg B | 2006 | Diabet Med2006，23，6： | 1 |
| 4 | Physic-chemical tool in Jurassic stratigraphy显示文摘 | Galbrum B Renard M | 1992 | Bulletin of Liason and Information of IUGS Subcom mission on Geochronology1992，10，： | 1 |
| 5 | Dynamic shortest paths minimizing travel times and costs显示文摘 | Ahuja R K Odin J B Pallottino S | 2003 | Networks2003，41，： | 1 |
| 6 | MTHFR, MTR, and MTRR polymorphisms in relation to pl61NK4A hypermethylation in mucosa of patients with colorectal cancer显示文摘 | Wettergren Y Odin E Carlsson G Gustavsson B | 2010 | Mol Med2010，16，910： | 1 |
| 7 | Sensitivity analysis for shortest path problems and maximum capacity path problems in undirected graphs 显示文摘 | Ramkumar Ramaswamy James B Odin Nilopal Chakravarti | 2004 | Math program Ser A2004，7，7： | 1 |
| 8 | Real-world cure rates for hepatitis C virus treatments that include simeprevir and/or sofosbuvir are comparable to clinical trial results显示文摘AIM To assess the real-world effectiveness and cost of simeprevir(SMV), and/or sofosbuvir(SOF)-based therapy for chronic hepatitis C virus(HCV) infection.METHODS The real-world performance of patients treated with SMV/SOF ± ribavirin(RBV), SOF/RBV, and SOF/RBV with pegylated-interferon(PEG) were analyzed in a consecutive series of 508 patients with chronic HCV infection treated at a single academic medical center. Patients with genotypes 1 through 4 were included. Rates of sustained virological response-the absence of a detectable serum HCV RNA 12 wk after the end of treatment [sustained virological response(SVR) 12]-were calculated on an intention-to-treat basis. Costs were calculated from the payer's perspective using Medicare/Medicaid fees and Redbook Wholesale Acquisition Costs. Patient-related factors associated with SVR12 were identified using multivariable logistic regression.RESULTS SVR 12 rates were as follows: 86%(95%CI: 80%-91%)among 178 patients on SMV/SOF ± RBV; 62%(95%CI: 55%-68%) among 234 patients on SOF/RBV; and 78%(95%CI: 68%-86%) among 96 patients on SOF/PEG/RBV. Mean costs-per-SVR 12 were $174442(standard deviation: ± $18588) for SMV/SOF ± RBV; $223003(± $77946) for SOF/RBV; and $126496(± $31052) for SOF/PEG/RBV. Among patients on SMV/SOF ± RBV, SVR12 was less likely in patients previously treated with a protease inhibitor [odds ratio(OR): 0.20, 95%CI: 0.06-0.56]. Higher bilirubin(OR: 0.47, 95%CI: 0.30-0.69) reduced the likelihood of SVR12 among patients on SOF/RBV, while FIB-4 score ≥ 3.25 reduced the likelihood of SVR 12(OR: 0.18, 95%CI: 0.05-0.59) among those on SOF/PEG/RBV. CONCLUSION SVR 12 rates for SMV and/or SOF-based regimens in a diverse real-world population are comparable to those in clinical trials. Treatment failure accounts for 27% of costs. | Kian Bichoupan Neeta Tandon James F Crismale Joshua Hartman David Del Bello Neal Patel Sweta Chekuri Alyson Harty Michel Ng Keith M Sigel Meena B Bansal Priya Grewal Charissa Y Chang Jennifer Leong Gene Y Im Lawrence U Liu Joseph A Odin Nancy Bach Scott L Friedman Thomas D Schiano Ponni V Perumalswami Douglas T Dieterich Andrea D Branch | 2017 | World Journal of Virology2017，6，4： | 1 |
| 9 | A survey of very large-scale neighborhood search techniques 显示文摘 | I Ahuja R K Ergum O Odin J B | 2002 | Discrete Applied Mathematics2002，123，13： | 1 |
| 10 | Carotid artery intima-media thickness in patients with Type 2 diabetes mellitus and impaired glucose tolerance:a systematic review显示文摘 | Brohall G Odin A Fagerberg B | 2006 | Diabet Med2006，23，： | 1 |
| 11 | Faster Algorithms for the Shortest Path Problem 显示文摘 | Ahuja R K Mehlhom K Odin J B Tarjan R E | 1990 | Journal of the Association for Computing Machinery1990，37，2： | 1 |
| 12 | Anemia of uremia is associated with reduced in vitro cytokine secretion: immunopotentiating activity of red blood cells 显示文摘 | Gafter U Kaleehman Y Odin J B | 1998 | Kidney Int1998，45，1： | 1 |
| 13 | p16INK4a gene promoter hypermethylation in mucosa as a prognostic factor for patients with colorectal cancer 显示文摘 | Wettergren Y Odin E Gustavsson B | 2008 | Mol Med2008，14，78： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员